Announcing our 2022 Webinar Series!
Join us for breakfast, lunch or cocktails
for our monthly webinar series on Bioentrepreneurship.

In our 2022 "Things You Need to Know" series, we will learn from prominent scientists, entrepreneurs, and investors about their successes, struggles, and the things they wished they knew before starting their journey.  
"Backyard Business to Boardroom Executive"

The story behind the humble beginnings of the internationally-known company BioStatus (maker of Draq5) is a unique one, a journey which we will hear in delightful detail directly from its founder, Dr. Stefan Ogrodzynski.
The genesis of the company points to how opportunistic risk-taking, scientific insight, and hard work can bring about a durable and profitable bio-business model, one that now extends into other life science arenas.
Profits from the original company, along with the learnings and networking connections gained along the way, have now provided a strong foundation for ventures to discover novel medicines and to create reclaimed space for productive bio-incubators to help enable other fledgling start-ups.
Guest Speaker

Stefan Ogrodzinski is an experienced CEO and Board Director with a 25-year career spanning the pharmaceutical industry, healthcare, voluntary and educational sectors. He currently leads the OncoTherics Team in Poland and is an active entrepreneur in the Life Sciences sector, having founded and lead a number of successful private companies in the UK. Skilled in start-up formation, IPR positioning, small business growth and Corporate Governance, Stefan received his BSc (Hons) in Toxicology and Pharmacology from The School of Pharmacy, University College London in 1987 and his MBA from De Montfort University in 1999. In 2000, Stefan founded the award-winning Life Science company, BioStatus and remains responsible for the overall direction and strategic management of the business. He is also a Director of BioSuspensions and BioTherics (two early stage pharmaceutical ventures) and sits on the advisory panel for the Centre for Doctoral Training in Targeted Therapeutics and Formulation Science at Nottingham University.
Webinar Host

This Seminar series is hosted by the Academic Drug Discovery Consortium (ADDC). The ADDC is a professional society dedicated to building the community of academic drug discovery labs and the companies, universities, and government agencies that support and partner with these centers.  
Become a Sponsor!

Click to view webinar series sponsorship opportunities

Contact us for complete details